The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...
Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...
Zacks.com on MSN19h
Denali Gains 26.6% in a Year: How Should You Play the Stock?Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration ...
"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.
Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...
Opella reaches study milestone for Cialis Paris1, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its ...
SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity ...
In some good news for the US vaccines developer, whose stock has fallen 66% in the past 12 months, Moderna on Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback